Clinical trials

  • TOVORAFENIB for Pediatric low-grade glioma (RAF-altered)
  • BRENTUXIMAB VEDOTIN for Diffuse large B-cell lymphoma (DLBCL) | Non-Hodgkin lymphoma (NHL)
  • Dimethyl fumarate for Age-related macular degeneration | Geographic atrophy
  • NAMODENOSON for Non-alcoholic steatohepatitis (NASH) with F1-3 fibrosis
  • INCLISIRAN (Inclisiran sodium) for Atherosclerotic cardiovascular disease (ASCVD)
  • Clinical trial in Malignant melanoma
  • CRIZANLIZUMAB for Sickle cell disease
  • NX-5948 for Relapsed or refractory B-cell malignancies | Diffuse large B-cell lymphoma | Mantle cell lymphoma | Follicular lymphoma | Marginal zone lymphoma | Splenic marginal zone lymphoma | B-cell chronic lymphocytic leukemia | Waldenström macroglobulinemia | Primary central nervous system lymphoma | B-cell small lymphocytic lymphoma
  • LUTIKIZUMAB for Hidradenitis suppurativa
  • belantamab mafodotin for Relapsed/refractory multiple myeloma | Multiple myeloma
  • Allogeneic adipose-derived mesenchymal stem cells in vitro expanded for Chronic active antibody-mediated rejection
  • [11C]HSP990 for Alzheimer's disease|Amyotrophic lateral sclerosis|Parkinson's disease